BEUDAMED
    FDA Adverse Event Death Summary report: N

    EUFLEXXA 20 MG/2ML (6=3 SYR

    MDR report key: 22327767 · Received June 24, 2025

    Report

    Report Number
    MW5171876
    Event Type
    Death
    Date Received
    June 24, 2025
    Report Date
    June 20, 2025
    Manufacturer
    FERRING PHARMACEUTICALS INC.
    Product Code
    MOZ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    PHARMACIST
    Health Professional
    N

    Narratives

    Description of Event or Problem · 0

    PT'S NURSE (B)(6) REPORTS THE PT HAS PASSED AWAY. NO OTHER INFO WAS PROVIDED. FREQ: INJECT CONTENT OF ONE SYRINGE INTRA-ARTICULARLY INTO RIGHT KNEE ONCE WEEKLY FOR THREE WEEKS. (B)(6).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1873384 EUFLEXXA 20 MG/2ML (6=3 SYR ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS INC.

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Male Death